Clinical Trial Update: Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating dulaglutide with insulin microsecretion in adults with type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Adult Subjects With Type1Diabetes and Insulin Microsecretion | Phase 2 | Status: COMPLETED